Merck & Co Inc
NYSE: MRK
$99.45
+$0.08 (+0.1%)
Closing Price on December 24, 2024
MRK Articles
The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks increased.
Published:
Last Updated:
One strategy that has been popular each year as investors rebalance and make changes is the so-called Dogs of the Dow.
Published:
Last Updated:
With the passage of tax reform looking almost certain, and with companies continuing to prove that all-time highs in the market will not hurt spending cash on share buybacks, the continuation of...
Published:
Last Updated:
Caterpillar, UnitedHealth, Merck, and Verizon were among the largest losers among DJIA stocks on Thursday.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
Apple, Disney, Merck, and Pfizer were the leading gainers among the Dow 30 stocks on Monday. Bitcoin settled up 23% after its first trading session.
Published:
Last Updated:
The question for investors is pretty simple: 2017 was great, but what do they do for an encore in 2018?
Published:
Last Updated:
Some down and out stocks don't always stay down, and sometimes great turnarounds and recoveries can create huge victories for opportunistic and visionary investors.
Published:
Last Updated:
Microsoft and Vise were Wednesday's big DJIA gainers while Merck and Disney dipped the most.
Published:
Last Updated:
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
Published:
Last Updated:
One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be “deep value” plays at Merrill Lynch.
Published:
Merck, Omega Health, Cardinal Health, and Curis all posted new 52-week lows Monday.
Published:
Last Updated:
Intel, Merck, McDonald's, and Exxon Mobil weighed on the DJIA Friday.
Published:
Last Updated:
The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Merrill Lynch points to five companies that, in their words, should be key players in the young but growing biosimilar market.
Published:
Last Updated: